| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |